Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 12,006,874        
Balance at Dec. 31, 2019   $ 64,232,000 $ 2,000 $ (56,617,000) $ 7,617,000
Exercise of common stock options (in shares) 7,200        
Exercise of common stock options   16,000     16,000
Share-based compensation expense   393,000 0 0 393,000
Unrealized gain (loss) on marketable securities     40,000   40,000
Net loss       (2,425,000) (2,425,000)
Issuance of common shares net of offering costs (in shares) 2,125,000        
Issuance of common shares net of offering costs   7,682,000     7,682,000
Balance (in shares) at Mar. 31, 2020 14,139,074        
Balance at Mar. 31, 2020   72,323,000 42,000 (59,042,000) 13,323,000
Balance (in shares) at Dec. 31, 2019 12,006,874        
Balance at Dec. 31, 2019   64,232,000 2,000 (56,617,000) $ 7,617,000
Exercise of common stock options (in shares)         7,200
Exercise of common stock options         $ 16,000
Unrealized gain (loss) on marketable securities         27,000
Net loss         (4,899,000)
Balance (in shares) at Jun. 30, 2020 14,139,074        
Balance at Jun. 30, 2020   72,759,000 29,000 (61,516,000) 11,272,000
Balance (in shares) at Mar. 31, 2020 14,139,074        
Balance at Mar. 31, 2020   72,323,000 42,000 (59,042,000) 13,323,000
Share-based compensation expense   436,000 0 0 436,000
Unrealized gain (loss) on marketable securities     (13,000)   (13,000)
Net loss       (2,474,000) (2,474,000)
Balance (in shares) at Jun. 30, 2020 14,139,074        
Balance at Jun. 30, 2020   72,759,000 29,000 (61,516,000) 11,272,000
Balance (in shares) at Dec. 31, 2020 18,746,157        
Balance at Dec. 31, 2020   94,925,000 (2,000) (68,909,000) 26,014,000
Exercise of common stock options (in shares) 40,000        
Exercise of common stock options   244,000     244,000
Share-based compensation expense   511,000     511,000
Unrealized gain (loss) on marketable securities     (2,000)   (2,000)
Net loss       (3,622,000) (3,622,000)
Balance (in shares) at Mar. 31, 2021 18,786,157        
Balance at Mar. 31, 2021   95,680,000 (4,000) (72,531,000) 23,145,000
Balance (in shares) at Dec. 31, 2020 18,746,157        
Balance at Dec. 31, 2020   94,925,000 (2,000) (68,909,000) $ 26,014,000
Exercise of common stock options (in shares)         40,000
Exercise of common stock options         $ 244,000
Unrealized gain (loss) on marketable securities         1,000
Net loss         (6,896,000)
Balance (in shares) at Jun. 30, 2021 18,786,157        
Balance at Jun. 30, 2021   96,126,000 (3,000) (75,805,000) 20,318,000
Balance (in shares) at Mar. 31, 2021 18,786,157        
Balance at Mar. 31, 2021   95,680,000 (4,000) (72,531,000) 23,145,000
Share-based compensation expense   446,000     446,000
Unrealized gain (loss) on marketable securities     1,000   1,000
Net loss       (3,274,000) (3,274,000)
Balance (in shares) at Jun. 30, 2021 18,786,157        
Balance at Jun. 30, 2021   $ 96,126,000 $ (3,000) $ (75,805,000) $ 20,318,000